One participant communicated with a remote private provider via Skype and enjoys using this method of communication. f. Despite variability in patient preferences regarding learning their cholesterol levels, patients agreed it was important to hear about the available screening tests. In addition, patients believed it is important that they understand their lipid levels and lipid profile results. All three participants have their lipids tested every six months as recommended by their provider. All three participants did not feel that fasting lipid testing was burdensome. Patient knowledge about lipid profiles varied. One patient used and advocated for providing advanced lipoprotein testing, while two participants were only aware of cholesterol, LDL, and HDL testing. All three participants felt that knowing their lipid profile has not made them feel better or worse, or improved their understanding of risk. Appendix F: Evidence Table Table F-1. Evidence Tablea,b,c Recommendation 2014 Strength of Recommendation Evidence 2020 Strength of Recommendation Recommendation Category 1. For primary prevention in patients over age 40 and not on statin therapy who have not developed new cardiovascular risk factors (e.g., diabetes, hypertension, tobacco use), we suggest against offering a cardiovascular disease risk assessment more frequently than every five years. Weak for [20,21] Weak against Reviewed, Amended 2. For primary prevention in patients not on statin therapy, we suggest against routinely ordering a lipid panel more frequently than every 10 years. Not applicable [21-23] Weak against Reviewed, New- added 3. For cardiovascular risk assessment in primary prevention, we suggest using a 10-year risk calculator. Weak for [24-28] Weak for Reviewed, Amended 4. We suggest against the routine use of coronary artery calcium testing. Weak against [29] Additional references: Weak against Reviewed, Not changed 5. We suggest against the routine use of additional risk markers (e.g.